| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. | Chief Business Officer | Common Stock | 31,100 | $9,258 | $0.2977 | 30 Aug 2023 | Direct |
| Eiger BioPharmaceuticals, Inc. | Chief Business Officer | Common Stock | 2,400 | $714 | $0.2977 | 30 Aug 2023 | By Family Trust |
| Eiger BioPharmaceuticals, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 54,000 | 31 Aug 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000090514823000841-choong-ingrid-2023-08-31 | Eiger BioPharmaceuticals, Inc. | 31 Aug 2023 | 1 | $0 | 4 | Chief Business Officer | 05 Sep 2023, 21:38 |
| /report/000090514823000840-choong-ingrid-2023-08-30 | Eiger BioPharmaceuticals, Inc. | 30 Aug 2023 | 0 | $0 | 3 | Chief Business Officer | 05 Sep 2023, 21:35 |